For investors, there are few things sweeter than a company that's capable of building its bottom line year after year despite taking risks by entering new lines of business to keep growth going. In early 2028, pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will likely be a larger and more diversified business, assuming its foray into primary care goes according to plan. 

But if its entry into new markets hits a speed bump, it could leave the door open for competitors to eat its lunch. So, what'll happen to Walgreens over the pivotal period of the next five years? Let's find out by mapping out its objectives and its recent progress toward them. 

The pharmacy company finds itself in the midst of an attempt to diversify into providing healthcare services like primary care during a time when its top and bottom lines are looking somewhat weak. Take a look at this chart:

Continue reading

Source Fool.com